SMYD3 and cancer: Knockdown of SMYD3 has been reported to decrease cell proliferation in a wide variety of cancers [6,7,10,15,22,23,32,35,36,40,41,42], while its overexpression promotes cell growth, transformation and reduces apoptosis sensitivity [6,43].